Get the Stockscreener App
2.13
0.47%
0.010
After Hours:
2.06
-0.07
-3.29%
Sunshine Biopharma Inc stock is traded at $2.13, with a volume of 57,001.
It is up +0.47% in the last 24 hours and down -58.24% over the past month.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
See More
Previous Close:
$2.12
Open:
$2.08
24h Volume:
57,001
Relative Volume:
0.04
Market Cap:
$4.52M
Revenue:
$35.49M
Net Income/Loss:
$-6.04M
P/E Ratio:
-0.1636
EPS:
-13.0191
Net Cash Flow:
$-6.42M
1W Performance:
-10.13%
1M Performance:
-58.24%
6M Performance:
-84.40%
1Y Performance:
-85.56%
1-Day Range:
$2.06
$2.165
1-Week Range:
$2.06
$2.4499
52-Week Range:
$2.01
$24.30
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Name
Sunshine Biopharma Inc
Sector
Phone
954-330-0684
Address
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
2.13 | 4.52M | 35.49M | -6.04M | -6.42M | -13.02 |
TAK
Takeda Pharmaceutical Co Adr
|
15.63 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.96 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.48 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.71 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
536.59 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
Sunshine Biopharma Inc Stock (SBFM) Latest News
Sunshine Biopharma Inc (SBFM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sunshine Biopharma Inc (SBFM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sunshine Biopharma Inc (SBFMW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sunshine Biopharma Inc (SBFMW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sunshine Biopharma Inc (SBFMW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sunshine Biopharma Inc (SBFM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sunshine Biopharma Inc (SBFM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sunshine Biopharma Inc (SBFM) Institutional Confidence - TradingKey
Sunshine Biopharma Inc (SBFM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sunshine Biopharma Inc (SBFM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sunshine Biopharma Inc (SBFMW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sunshine Biopharma Inc (SBFMW) Institutional Confidence - TradingKey
Sunshine Biopharma Inc (SBFMW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sunshine Biopharma Inc (SBFMW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sunshine Biopharma Inc (SBFMW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SBFM SEC FilingsSunshine Biopharma Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Sunshine Biopharma (SBFM) Holds Near Support After Marginal Gains Amid Biotech Sector VolatilityVirgin POC - newsline.com
Sunshine Biopharma (SBFM) Slips 6% as Stock Tests Key Support at $2.11RVOL Spike - newsline.com
Sunshine Biopharma Company Profile & Introduction - Moomoo
Sunshine Biopharma (SBFM) Shows Modest Gains, Holds Above Key SupportDelta Hedging - newsline.com
$Sunshine Biopharma (SBFM.US)$ - Moomoo
Sunshine Biopharma Inc Stock Short Interest Rises to 68.28% - Quiver Quantitative
Sunshine Biopharma (NASDAQ: SBFM) approves Series C warrant provisions after reverse split - Stock Titan
Sunshine Biopharma (SBFM) Slips 2.44% as Stock Holds Above Key SupportPut Flow Alert - newsline.com
Sunshine Biopharma Inc. (SBFM) Q1 2026 Earnings: Pre‑Revenue Biotech Reports Net Loss, Stock Declines - newsline.com
😭😭😭 - Moomoo
$Sunshine Biopharma (SBFM.US)$ :( - Moomoo
SBFM Stock Jumps As Sunshine Biopharma Secures New Drug Approvals - StocksToTrade
Sunshine Biopharma (SBFM) Gains Approval for Generic Rivaroxaban in Canada - GuruFocus
Sunshine Biopharma announces Canadian approval for Rivaroxaban - TipRanks
Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R) - guardonline.com
Generic Xarelto pill from Sunshine Biopharma wins Canada approval - Stock Titan
Why Sunshine Biopharma (SBFM) stock dropped after hours today - MSN
Sunshine Biopharma Stock Quote, Share Price, News and Analysis - Longbridge
SBFM Q1 2026 Earnings: Reported Loss of -$0.25 Per Share as Clinical Pipeline AdvancesEarnings Call Transcript - newsline.com
Sunshine Biopharma (SBFM) Secures Patent for Coronavirus Treatme - GuruFocus
Sunshine Biopharma Approves Dilutive Share and Warrant Actions - TipRanks
Sunshine Biopharma (SBFM) approves warrant provisions after May 19 offering - Stock Titan
Major holder of Sunshine Biopharma (NASDAQ: SBFM) approves share and Series C warrant terms - Stock Titan
Sunshine Biopharma receives patent for coronavirus treatment compounds By Investing.com - Investing.com South Africa
Sunshine Biopharma receives patent for coronavirus treatment compounds - Investing.com
Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology - New Castle News
New coronavirus patent aims to keep treatments working as virus mutates - Stock Titan
Sunshine Biopharma stock tumbles after reverse split announcement - Investing.com
Sunshine Biopharma drops 5.17% after announcing a one-for-ten reverse stock split. - Pluang
Why Sunshine Biopharma (SBFM) Stock Dropped After Hours Today - Benzinga
Sunshine Biopharma announces 1-for-10 reverse stock split - Investing.com UK
Sunshine Biopharma Announces 1-for-25 Reverse Stock Split Effective May 29, 2026 - geneonline.com
Sunshine Biopharma (SBFM) Implements Reverse Stock Split for Nas - GuruFocus
Sunshine Biopharma stock tumbles after reverse split announcement By Investing.com - Investing.com Australia
Sunshine Biopharma announces 1-for-10 reverse stock split By Investing.com - Investing.com Nigeria
Sunshine Biopharma Inc Stock (SBFM) Financials Data
Revenue
Net Income
Cash Flow
EPS
11.23%
0.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):